Cargando…

Very late onset post-transplant diffuse large B cell lymphoma in a liver transplant recipient with hepatitis B: A case report

RATIONALE: Post transplantation lymphoproliferative disorder (PTLD) is a rare but severe complication. Epstein-Barr virus (EBV) is considered an important pathogen for PTLD and EBV deoxyribonucleic acid (DNA) load is widely monitored to detect PTLD early. Hepatitis B virus (HBV) infection is rarely...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Fan, Huang, Yuehua, Wang, Yanying, Yu, Zhuo, Li, Xinquan, Dong, Jiahong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6221709/ https://www.ncbi.nlm.nih.gov/pubmed/30383683 http://dx.doi.org/10.1097/MD.0000000000013063

Ejemplares similares

Significance of Hepatitis B Recurrence in Liver Transplantation Recipients
por: Chou, Hong-Shiue, et al.
Publicado: (2020)

Colonic Diffuse Large B-Cell Lymphoma in a Liver Transplant Patient with Historically Very Low Tacrolimus Levels
por: Moore, Christopher M., et al.
Publicado: (2012)

A Hepatitis B Virus Reactivation Case Potentially Triggered by the Onset of Diffuse Large B Cell Lymphoma
por: Sato, Kentaro, et al.
Publicado: (2022)

Epstein-Barr Virus-Negative Diffuse Large B-Cell Post-transplant Lymphoma in an Epstein-Barr Virus-Positive Recipient
por: Lee, Charlotte, et al.
Publicado: (2021)

Epidemiology and Outcomes of Early-Onset and Late-Onset Adenovirus Infections in Kidney Transplant Recipients
por: Bruminhent, Jackrapong, et al.
Publicado: (2019)

Primary Hepatic Burkitt Lymphoma in a Kidney Transplant Recipient
por: Lionaki, Sophia, et al.
Publicado: (2018)

Prevalence of occult hepatitis B virus infection in kidney transplant recipients
por: Franz, Cibele, et al.
Publicado: (2013)

Hepatitis B Virus Reactivation in Kidney Transplant Recipients Treated With Belatacept
por: Schwarz, Chloë, et al.
Publicado: (2023)

The Role of Autologous Stem Cell Transplantation in the Treatment of Diffuse Large B-Cell Lymphoma
por: Gunnellini, Marco, et al.
Publicado: (2012)

Primary hepatic diffuse large B cell lymphoma: A case report: Primary hepatic diffuse large B cell lymphoma
por: Ma, Yuan-Ji, et al.
Publicado: (2011)

Late-onset severe hepatic sinusoidal obstruction syndrome in an allogeneic stem cell transplant recipient: A case report
por: Sun, Yan-ling, et al.
Publicado: (2020)

1110. Very Late Onset Infections Amongst Long Term Survivors of Kidney Transplantation
por: Cheung, Harry, et al.
Publicado: (2020)

Serum Apolipoprotein B and A1 Concentrations Predict Late-Onset Posttransplant Diabetes Mellitus in Prevalent Adult Kidney Transplant Recipients
por: Malyala, Rohit, et al.
Publicado: (2019)

Characterization of occult hepatitis B infection among Iranian liver transplant recipients
por: Khamseh, Azam, et al.
Publicado: (2022)

Reactivation of occult hepatitis B virus infection in a renal transplant recipient
por: Jiang, Lili, et al.
Publicado: (2022)

High dose chemotherapy with autologous stem cell transplantation in diffuse large B-cell lymphoma
por: Mey, Ulrich J.M., et al.
Publicado: (2007)

Autologous stem cell transplantation for diffuse large B-cell lymphoma with residual extranodal involvement
por: Ko, Ock Bae, et al.
Publicado: (2008)

R-CHOP chemoimmunotherapy followed by autologous transplantation for the treatment of diffuse large B-cell lymphoma
por: Lee, Hong Ghi, et al.
Publicado: (2014)

Late presentation of toxoplasmosis in renal transplant recipients
por: Clissold, Rhian, et al.
Publicado: (2010)

Risk Stratification for Hepatitis B Virus Reactivation in Kidney Transplant Recipients With Resolved HBV Infection
por: Tsai, Hsin-Ju, et al.
Publicado: (2023)

Capable Infection of Hepatitis B Virus in Diffuse Large B-cell Lymphoma
por: Wang, Yanchun, et al.
Publicado: (2018)

Late onset tacrolimus-induced life-threatening polyneuropathy in a kidney transplant recipient patient
por: Renard, Delphine, et al.
Publicado: (2012)

Early‐ and late‐onset posttransplant lymphoproliferative disorders among adult kidney and liver transplant recipients
por: Abdulovski, Ranya, et al.
Publicado: (2022)

Single-institution Retrospective Analysis of Prognostic Factors Influencing Very Late-onset Post-transplant Lymphoproliferative Disorder
por: Bishnoi, Rohit, et al.
Publicado: (2020)

Late post-transplant erythrocytosis in a hepatitis C-positive allograft recipient on sirolimus
por: Ali, A. A. M., et al.
Publicado: (2011)

BK virus pneumonia following stem cell transplantation against diffuse large B‐cell lymphoma
por: Yoshimura, Akihiro, et al.
Publicado: (2018)

Polatuzumab Vedotin for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma in Transplant-Ineligible Patients
por: Douglas, Melanie
Publicado: (2020)

Immunophenotype classification and therapeutic outcomes of Chinese primary gastrointestinal diffuse large B-cell lymphoma
por: Zhang, Zizhen, et al.
Publicado: (2012)

Poor Prognosis of Diffuse Large B-Cell Lymphoma with Hepatitis C Infection
por: Tsai, Yu-Fen, et al.
Publicado: (2021)

Return to work for patients with diffuse large B-cell lymphoma and transformed indolent lymphoma undergoing autologous stem cell transplantation
por: Arboe, Bente, et al.
Publicado: (2017)

Immune profiling in Diffuse Large B-Cell Lymphoma and Mantle Cell Lymphoma Patients treated with Autologous Hematopoietic Cell Transplant
por: Herr, Megan M., et al.
Publicado: (2019)

The Matching Status Between Donor and Recipient Hepatitis B Seroepidemiology Makes a Difference in Liver Transplantation for Hepatocellular Carcinoma
por: Lu, Di, et al.
Publicado: (2020)

Ofatumumab with iphosphamide, etoposide and cytarabine for patients with transplantation‐ineligible relapsed and refractory diffuse large B‐cell lymphoma
por: Paszkiewicz‐Kozik, Ewa, et al.
Publicado: (2022)

Disseminated Invasive Mucormycosis Infection Following Autologous Stem Cell Transplantation for Diffuse Large B-Cell Lymphoma
por: Cliff, Edward R. Scheffer, et al.
Publicado: (2023)

Autologous Transplantation May Still Effectively Treat Relapsed Diffuse Large B-Cell Lymphoma in Selected Patients
por: Bicsko, Reka Rahel, et al.
Publicado: (2023)

The salvage role of allogeneic hematopoietic stem-cell transplantation in relapsed/refractory diffuse large B cell lymphoma
por: Min, Gi-June, et al.
Publicado: (2023)

Minimal residual disease in patients with diffuse large B-cell lymphoma undergoing autologous stem cell transplantation
por: Merryman, Reid W., et al.
Publicado: (2022)

Anti-HBc impacts on the risk of hepatitis B reactivation but not on survival of solid-organ transplant recipients
por: Álvarez-López, Patricia, et al.
Publicado: (2020)

Impact of immunosuppressant therapy on new-onset diabetes in liver transplant recipients
por: Liu, Fu-Chao, et al.
Publicado: (2017)

Treated chronic hepatitis B is a good prognostic factor of diffuse large B-cell lymphoma
por: Park, Jeayeon, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rto9d638lcekl8msibnejfeuq8